Carson Wealth (CWM LLC)
PTGX icon

Carson Wealth (CWM LLC)’s Protagonist Therapeutics PTGX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.7K Buy
737
+181
+33% +$16K ﹤0.01% 3474
2025
Q4 		$49K Hold
556
– – ﹤0.01% 3623
2025
Q3 		$37K Sell
556
-53
-9% -$3.01K ﹤0.01% 3754
2025
Q2 		$34K Buy
609
+407
+201% +$19.5K ﹤0.01% 3557
2025
Q1 		$10K Sell
202
-184
-48% -$7.71K ﹤0.01% 4116
2024
Q4 		$15K Sell
386
-887
-70% -$38.7K ﹤0.01% 3636
2024
Q3 		$57K Buy
1,273
+1,147
+910% +$46.3K ﹤0.01% 2596
2024
Q2 		$4K Sell
126
-49
-28% -$1.44K ﹤0.01% 3994
2024
Q1 		$5K Buy
+175
New +$4.76K ﹤0.01% 3681
2023
Q4 		– Sell
-7
Closed – – 4445
2023
Q3 		$0 Hold
7
– – ﹤0.01% 4472
2023
Q2 		$0 Buy
+7
New +$175 ﹤0.01% 4409

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Carson Wealth (CWM LLC)'s PTGX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Protagonist Therapeutics (PTGX) stake by 33% in Q1 2026, buying an estimated $16K and bringing the position to 737 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3474.

Carson Wealth (CWM LLC) first reported a position in PTGX in Q2 2023 and has held it in 11 quarters since. 319 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 737 shares of Protagonist Therapeutics worth $77.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 181 Protagonist Therapeutics shares in Q1 2026, an estimated $16K.
  • Protagonist Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3474 holding.
  • Carson Wealth (CWM LLC) first reported a position in Protagonist Therapeutics in Q2 2023 and has held it in 11 quarters since.
  • 319 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.